Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by Berken IPEmilio Berkenwald of Berken IP examines Argentina’s continued absence from the Patent Cooperation Treaty, the practical consequences for patent filing strategies, and what possible accession could mean for local and foreign applicants -
Sponsored by InspicosNikolaj Riis Christensen of Inspicos considers whether the nine-month opposition period under the European Patent Convention is still fit for purpose
-
Sponsored by InventaDiogo Antunes of Inventa examines how personalised politics and campaign merchandising are bringing trademark law into the heart of Portugal’s presidential election
-
Sponsored by NLOWith relatively high opposition rates to granted food chemistry patents, Emily Flood and Gamze Gezer-Voerknecht of NLO explain how innovators can protect their intellectual property in an increasingly competitive and fast-moving market
-
Sponsored by Cabinet M OproiuRaluca Vasilescu of Cabinet M Oproiu finds that producing reliable, full patent applications remains a step too far for AI assistants at present
-
Sponsored by Spoor & FisherMatthew Costard of Spoor & Fisher Jersey outlines the key developments and says the modernisation of the country’s intellectual property regime presents immediate opportunities for brand owners
